ABSTRACT
Introduction Delirium is a common post-operative complication in critically ill patients, displaying transient changes in consciousness, inattention, awareness, and organized thought. Not a lot is known about the specific causes of this condition, as it is a complex physiologic state that is currently being unraveled to determine any correlation with imbalances in homeostasis.
Objective The aim of this systematic review is to report on and summarize risk factors associated with the development of postoperative delirium in critically ill adult patients.
Methods This systematic review assessed studies reporting on risk factors for postoperative delirium in critically ill patients. PubMed, PsycINFO, and CINAHL databases were searched for studies. Observational or interventional studies reviewing predictors for postoperative delirium in delirious versus non-delirious patients were included.
Results Fifty potential risk factors were identified and divided into eight subgroups. The significance of a specific risk factor for postoperative delirium was found to depend on the patient population in question, but consistently cited significant risk factors across cohorts included high mortality risk, abnormal laboratory values, and use of vasopressors, analgesics, thiopentones, propofol, and benzodiazepines. There was not enough evidence found to definitively state the significance of type of surgery being performed or cognitive impairment on development of this condition.
Conclusion Several risk factors were found to be significantly associated with the development of postoperative delirium, including high risk of mortality, specific medication use, and abnormal laboratory values. Further research needs to be performed to fully define the importance of these individual risk factors across broad critical care population.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NA, This is a systematic review paper
Funding Statement
Funding: A.B., T.O.B., and P.R. were supported by R01 GM110240 from the National Institute of General Medical Sciences. A.B. and T.O.B. were supported by Sepsis and Critical Illness Research Center Award P50 GM-111152 from the National Institute of General Medical Sciences. A.B. and M.R. were supported by Davis Foundation University of Florida. P.R. was supported by the NSF CAREER 1750192 and NIH/NIBIB 1R21EB027344 grants. T.O.B. received a grant supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR001427 and received a grant from Gatorade Trust (127900), University of Florida.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB approval or Consenting applicable, since this is a systematic review paper.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
NA. Systematic review paper
